Top Industry Leaders in the Pediatric Vaccines Market
Latest Pediatric Vaccines Companies Updates
Pfizer/BioNTech: Received FDA approval for their bivalent COVID-19 booster shots for children aged 5-11 years old.
Merck & Co.: Launched Vaxelis®, a new combination vaccine protecting against pneumococcal disease and meningococcal meningitis serogroups A, C, W, and Y.
GSK: Received FDA approval for Arexvy®, the first-ever RSV vaccine for adults aged 60 and older. (Indirectly benefitting the market by reducing RSV spread to children)
Pfizer's acquisition of Biohaven Pharmaceutical Holding Company: Gains access to Fazenda (migalastat), a medication approved for treating irritable bowel syndrome with diarrhea (IBS-D) in children.
GSK's collaboration with Clover Biopharmaceuticals: Jointly developing a next-generation vaccine for respiratory syncytial virus (RSV).
List of Pediatric Vaccines companies in the market:
-
GlaxoSmithKline plc
-
Merck Sharp & Dohme Corp.
-
SANOFI
-
AstraZeneca
-
Pfizer, Inc.
-
Zydus Cadila
-
Indian Immunologicals Limited
-
Serum Institute of India Pvt. Ltd.